Pharma shares were the top gainers led by Lupin after the company received EIR from USFDA for its Goa facility
Ajit Mishra, vice president, Research, Religare Broking, answers your queries
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances